TC BioPharm Announces Submission of Investigational New Drug Application to U.S. FDA for Treatment of RelapseRefractory AML
Slightly above 80 percent of all TC BioPharm's retail investors are aggressively thinking of buying. The analysis of overall sentiment of trading TC BioPharm Holdings pink sheet suggests that quite a few investors are excited at this time. TC BioPharm's investing sentiment overview a quick insight into current market opportunities from investing in TC BioPharm Holdings. Many technical investors use TC BioPharm Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
TCBP |
TC BioPharm PLC a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced submission of an Investigational New Drug application to the U.S. Food and Drug Administration for the use of TCB-008 in the treatment of relapserefractory Acute Myeloid Leukemia. TCB-008, an allogeneic unmodified gamma delta t-cell, is the Companys lead product and is currently in P
Read at finance.yahoo.com
 |
TC BioPharm Fundamental Analysis
We analyze TC BioPharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TC BioPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TC BioPharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
TC BioPharm is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
TC BioPharm Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TC BioPharm pink sheet to make a market-neutral strategy. Peer analysis of TC BioPharm could also be used in its relative valuation, which is a method of valuing TC BioPharm by comparing valuation metrics with similar companies.
Peers
TC BioPharm Related Equities
| ZVSA | ZyVersa Therapeutics | 15.79 | ||||
| PHIO | Phio Pharmaceuticals | 2.00 | ||||
| ZURA | Zura Bio | 2.00 | ||||
| RNAZ | Transcode Therapeutics | 1.46 | ||||
| IMMX | Immix Biopharma | 1.02 | ||||
| ALLR | Allarity Therapeutics | 2.11 | ||||
| SONN | Sonnet Biotherapeutics | 2.52 | ||||
| QNRX | Quoin Pharmaceuticals | 3.20 | ||||
| UNCY | Unicycive Therapeutics | 3.28 | ||||
| ICU | LMF Acquisition | 3.31 | ||||
| VRAX | Virax Biolabs | 7.62 | ||||
| BDRX | Biodexa Pharmaceticals | 8.70 | ||||
| PALI | Palisade Bio | 10.39 | ||||
| REVB | Revelation Biosciences | 14.98 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in TCBP Pink Sheet
If you are still planning to invest in TC BioPharm Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |